Abstract Purpose of Review Type 2 diabetes (T2D) and obesity are comorbidities that
generally progress with time even when non-invasive therapies are prescribed. Indeed …

Introduction There are several randomised controlled trials (RCTs) that have already shown
that metabolic/bariatric surgery achieves short-term and long-term glycaemic control while …

Background In recent years, bariatric surgery was found to have therapeutic potential for the
treatment of type 2 diabetes (T2D) in severely obese patients (body mass index [BMI]≥ 35 …

Background Metabolic surgery is a standard treatment for obesity with type 2 diabetes (T2D),
although the effects of metabolic surgery on the incidence rate of microvascular …

Background: The association between obesity and a reduction in life expectancy is well
established, and cardiovascular disease is a leading cause of mortality. Bariatric surgery …

Background Type-2 diabetes mellitus (T2DM) results in detrimental vascular complications
including both microvascular and macrovascular diseases. Roux-en-Y gastric bypass …

In recent years, a marked increase in the relative use of sleeve gastrectomy (SG) has
occurred. However, long-term head-to-head comparison of the impact of this bariatric …

Bariatric surgery was initially developed as a tool for weight reduction only, but it is gaining
increasing popularity because of its remarkable effect on glucose metabolism in morbidly …

Importance Controlling glycemia, blood pressure, and cholesterol is important for patients
with diabetes. How best to achieve this goal is unknown. Objective To compare Roux-en-Y …

The incidence of type 2 diabetes (T2D) continues to rise worldwide. The management of
T2D is challenging and therefore amenable to multimodality treatment options. Many …